Antibody Technologies Market Research Reports & Industry Analysis
Antibody technologies involve the use of specialized proteins called antibodies to target and detect specific molecules, often used in medical diagnostics, therapeutics, and research. This field is evolving quickly due to scientific advancements and the growing demand for personalized treatments. To help you stay updated on the latest developments, MarketResearch.com offers a comprehensive collection of reports on antibody technologies.
Valuable Antibody Technologies Research and Analysis
- Find detailed data on various market segments including precision medicine, biosimilars, biologics, protein engineering, and more.
- Obtain antibody technologies market sizing and growth projections, discussions of key drivers and challenges, pricing and regulatory analysis, and company profiles.
- Read expert commentary on recent technological innovations and industry trends to gain a clear understanding of emerging opportunities.
Your Research Partner
Whether you're an experienced industry professional, a consultant, or a busy executive, our antibody technologies market research reports are designed to help you make informed decisions. With reliable data and thorough analyses, these reports support your decision-making process. By choosing MarketResearch.com, you can gain the intelligence needed to stay competitive and take advantage of new opportunities.
Antibody Technologies Industry Research & Market Reports
-
Monoclonal Antibodies Market - Growth, Trends, COVID-19 Impact, and Forecast(2022 - 2027)
... halted due to the COVID-19 pandemic, and it severely affected the global monoclonal antibodies market as they are widely used in cancer and gene therapy, thus affecting the global monoclonal antibodies market. Although COVID-19 was ... Read More
-
Neuroscience Antibodies and Assays Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... research relies heavily on antibodies that help in identify and elucidate reactions on the cellular, molecular, and biochemical level, which may lead to a better understanding of a variety of neuroscience processes and neuronal diseases. ... Read More
-
Canine Atopic Dermatitis Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)
... of USD 1,107.86 million in 2026, with a CAGR of 8.46% over the forecast period (2021-2026). The impact of COVID-19 on the canine atopic dermatitis market is expected to be significant. As per the data ... Read More
-
China ulcerative colitis market, by Drug Therapy (5-Aminosalicylates, Monoclonal Antibodies, Steroids, Immunomodulators, and Antibiotics), by Route of Administration (Oral and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... and Opportunity Analysis, 2021 - 2028 Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. ... Read More
-
Next-Generation Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutic Area (Oncology and Autoimmune or Inflammatory) and Technology (Antibody-Drug Conjugates, Bispecific Antibodies, Fc Engineered Antibodies, Antibody Fragments and Antibody-Like Proteins, and Biosimilar Antibody Products
... Biosimilar Antibody Products The global next-generation antibody market is expected to reach US$ 12,050.13 million by 2028 from US$ 5,428.41 million in 2021; it is estimated to grow at a CAGR of 11.9% from 2021 ... Read More
-
Intravenous Immunoglobulin (IVIG) - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Intravenous Immunoglobulin (IVIG) Understanding The ... Read More
-
Antibody Drug Conjugate - Market Insight, Epidemiology and Market Forecast -2032
... in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Antibody Drug Conjugate market report provides current treatment practices, emerging drugs, Antibody Drug Conjugate market share of the individual therapies, ... Read More
-
Anti-CD80 Antibody - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2022
... of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the ... Read More
-
COVID-19 Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Mode (PoC, Non-PoC); By Product & Service Type; By Sample Type; By Test Type; By End Use; By Region; Segment Forecast, 2022 - 2029
... global COVID-19 diagnostics market size is expected to reach USD 283.93 billion by 2029 according to a new study by Polaris Market Research. The report “COVID-19 Diagnostics Market Share, Size, Trends, Industry Analysis Report, By ... Read More
-
Anti-CD19 Antibody - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Targeted Therapeutics Market - By Type (Monoclonal Antibodies, Small Molecular Inhibitors, Prodrug, And Nano-Particulate Antibody Conjugates), By Application (Breast Cancer, Leukemia, Colorectal Cancer, Lymphoma, Renal Cancer, Multiple Sclerosis, Wet Age-Related Macular Degeneration, And Lung Cancer), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, And Retail Pharmacies),And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030
... By Distribution Channel (Hospital Pharmacies, Online Pharmacies, And Retail Pharmacies),And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Targeted Therapeutics Market - ... Read More
-
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2022
... of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the ... Read More
-
Anti-CD28 Antibody - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Anti-CD279 ... Read More
-
Anti-CD3 Antibody - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032
... Versus Host Disease (GvHD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Graft Versus Host Disease (GvHD) market report provides current treatment practices, emerging drugs, Graft ... Read More
-
CD137 Agonist Antibody - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage CD137 ... Read More
-
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Immunoglobulin inhibitors - Pipeline Insight, 2022
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Immunoglobulin inhibitors Understanding ... Read More
-
Anti-CD52 Antibody - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Anti GM-CSF Antibody - Pipeline Insight, 2022
... of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the ... Read More
-
Anti-CD33 Antibody - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Biologics - Market Insights, Competitive Landscape and Market Forecast–2026
... By Manufacturing Type (In-House And Outsourced), and by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising prevalence of autoimmune disorders such as rheumatoid arthiritis and genetic disorders Global ... Read More
-
Biopharmaceuticals Market by Product (Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, And Others) and by Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, And Others)- Global Opportunity Analysis and Industry Forecast 2022-2030
... Opportunity Analysis and Industry Forecast 2022-2030 The Biopharmaceuticals Market was valued at USD 345.84 billion in 2021 and is predicted to reach USD 974.48 billion by 2030 with a CAGR of 11.7% from 2022-2030. Biopharmaceutical ... Read More
Research Assistance
